|
Summary Information: LogicBio Therapeutics Inc. Common Stock NASDAQ:LOGC |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a new approach to precise gene insertion that harnesses a cell's natural DNA repair process leading to durable therapeutic protein expression levels. LogicBio's cutting-edge sAAVy™ capsid development platform is designed to support development of treatments in a broad range of indications and tissues. The company is based in Lexington, MA.
__The following are links to various summary and news pages for __LogicBio Therapeutics Inc. Common Stock [ LOGC ]. __Note: Some Links might not have information for the company. |
|